✦ LIBER ✦

Clinical Outcome of HER2-positive Breast Cancer Patients after Failure on Adjuvant Trastuzumab: The Potential of the Time to Relapse

✍ Scribed by Di Cosimo, S.; Serpico, D.; Porcu, L.; Molino, L.; Fanetti, G.; Torri, V.; de Braud, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of adjuvant/neoadjuvant trastuzum

✍ Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, El 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Management and Outcome of HER2-Positive

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

Trastuzumab Retreatment after Relapse on

✍ Láng, I.; Bell, R.; Feng, F.Y.; Lopez, R.I.; Jassem, J.; Semiglazov, V.; Al-Saka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 448 KB

The influence of adjuvant chemotherapy o

✍ Houston, S.J; Richards, M.A; Bentley, A.E; Smith, P; Rubens, R.D 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 690 KB

Clinical outcomes and treatment practice

✍ Olson, Erin M.; Najita, Julie S.; Sohl, Jessica; Arnaout, Amal; Burstein, Harold 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Retrospective Evaluation of Clinical Out

✍ Filippo Montemurro; Stefania Redana; Giuseppe Viale; Giuseppina Sanna; Michela D 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB